Oncolytics Biotech, Inc.
ONCY
Get informed when a big investor buys or sells
+ FollowMarket Cap$85.97M
Close$
$0.05
94.6% downside
Current Fair Value
94.6% downsideOvervalued by 94.6% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $85.97 Million |
|---|---|
| Enterprise Value | $82.30 Million |
| Dividend Yield | $- (-) |
| Earnings per Share | $-0.41 |
| Beta | 1.14 |
| Outstanding Shares | 119,739,942 |
Return
| Return on Equity | 560.92% |
|---|---|
| Return on Assets | -450.95% |
| Return on Invested Capital | -1420.73% |
Valuation & Multiples
| P/E Ratio | -3.46 |
|---|---|
| PEG | -6.51 |
| Price to Sales | - |
| Price to Book Ratio | -0.88 |
| Enterprise Value to Revenue | - |
| Enterprise Value to EBIT | -2.37 |
| Enterprise Value to Net Income | -3 |
| Total Debt to Enterprise | 0.01 |
| Debt to Equity | -0.07 |
Revenue Sources
No data
Insider Trades
Last Earnings Call
Report Date
August 14, 2026
EPS Estimate
$-0.05
Average shareholder expectationRevenue Estimate
-
Average shareholder expectationNext Earnings Call
Expected Date
October 30, 2026
EPS Estimate
$-0.06
Average shareholder expectationRevenue Estimate
-
Average shareholder expectationInstitutional Put/Call Ratio
Market sentiment based on institutional option activity.
| Put/Call Ratio | 0.00000% |
|---|---|
| Total Calls | - |
| Total Puts | - |
Institutional Ownership
Holdings and activity of institutional investors.
| Ownership % | 3.51%▲ 0.84% |
|---|---|
| Total Invested | $3.74M▲ 43.38% |
| Investors Holding | 77▲ 20.00% |
ESG Score
No data